The level of deletion 17p and bi-allelic inactivation of TP53 has a significant impact on clinical outcome in multiple myeloma.

ABSTRACT:

SUBMITTER: Thanendrarajan S 

PROVIDER: S-EPMC5685226 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature